Literature DB >> 4077963

Zygomycosis caused by Apophysomyces elegans.

M A Wieden, K K Steinbronn, A A Padhye, L Ajello, F W Chandler.   

Abstract

A case of zygomycosis caused by Apophysomyces elegans in a diabetic, obese female is described. The fungus gained entry into the body through injury to the skin, penetrating the keratin, epidermis, and dermis. Hyphal angioinvasion was observed. Fungal elements invaded the subcutaneous fat, skeletal muscle fibers, nerves, and large blood vessels, resulting in the spread of the infection. The rapidity with which A. elegans invaded the blood vessels left no choice except amputation of the leg to stop the spread of the infection. This zygomycetous fungus closely resembles Absidia corymbifera. It is distinguished by its prominent campanulate apophyses. In its gross colony characteristics and failure to sporulate on routinely used media it resembles Saksenaea vasiformis.

Entities:  

Mesh:

Year:  1985        PMID: 4077963      PMCID: PMC268459          DOI: 10.1128/jcm.22.4.522-526.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis.

Authors:  L Ajello; D F Dean; R S Irwin
Journal:  Mycologia       Date:  1976 Jan-Feb       Impact factor: 2.696

2.  Disseminated zygomycosis (mucormycosis) caused by Saksenaea vasiformis.

Authors:  R J Hay; C K Campbell; W M Marshall; B I Rees; J Pincott
Journal:  J Infect       Date:  1983-09       Impact factor: 6.072

3.  Nosocomial invasive Saksenaea vasiformis infection.

Authors:  A D Oberle; R L Penn
Journal:  Am J Clin Pathol       Date:  1983-12       Impact factor: 2.493

  3 in total
  15 in total

1.  Burn wound zygomycosis caused by Apophysomyces elegans.

Authors:  R D Cooter; I S Lim; D H Ellis; I O Leitch
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Apophysomyces elegans: a novel cause of endogenous endophthalmitis in an immunocompetent individual.

Authors:  Vivek Pravin Dave; Savitri Sharma; Rohit Yogi; Swapna Reddy
Journal:  Int Ophthalmol       Date:  2014-09-03       Impact factor: 2.031

Review 3.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Osteomyelitis of the sternum caused by Apophysomyces elegans.

Authors:  M E Eaton; A A Padhye; D A Schwartz; J P Steinberg
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

5.  Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern.

Authors:  A Chakrabarti; M R Shivaprakash; I Curfs-Breuker; A Baghela; C H Klaassen; J F Meis
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

6.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 7.  Opportunistic zygomycotic infections. A literature review.

Authors:  A Espinel-Ingroff; L A Oakley; T M Kerkering
Journal:  Mycopathologia       Date:  1987-01       Impact factor: 2.574

8.  Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis.

Authors:  A A Padhye; L Ajello
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

9.  Rhizopus arrhizus in Italy as the causative agent of primary cerebral zygomycosis in a drug addict.

Authors:  S Oliveri; E Cammarata; G Augello; P Mancuso; R Tropea; L Ajello; A A Padhye
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

Review 10.  Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.

Authors:  Kimberly P Liang; Imad M Tleyjeh; Walter R Wilson; Glenn D Roberts; Zelalem Temesgen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.